Shanghai Model Organisms Center (SHSE:688265) ROE %: 0.16% (As of Mar. 2026) — 96% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688265 Shanghai Model Organisms Center Inc SHSE:688265
78 GF Score
Price ¥31.62
GF Value ¥47.95
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Shanghai Model Organisms Center ROE %?

Shanghai Model Organisms Center SHSE:688265 -2.14% 78 ROE % is 0.16% as of Mar. 2026, which is 96% below its 10-year median of 3.91. GuruFocus rates SHSE:688265 with a GF Score™ of 78/100 and a GF Value™ of ¥47.95 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 1,249 Biotechnology companies, Shanghai Model Organisms Center ranks better than 80.3% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Shanghai Model Organisms Center's annualized net income for the quarter that ended in Mar. 2026 was ¥2.7 Mil. Shanghai Model Organisms Center's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was ¥1,711.0 Mil. Therefore, Shanghai Model Organisms Center's annualized ROE % for the quarter that ended in Mar. 2026 was 0.16%.

The historical rank and industry rank for Shanghai Model Organisms Center's ROE % or its related term are showing as below:

SHSE:688265' s ROE % Range Over the Past 10 Years
Min: -18.63   Med: 3.91   Max: 22.83
Current: 1.95

During the past 12 years, Shanghai Model Organisms Center's highest ROE % was 22.83%. The lowest was -18.63%. And the median was 3.91%.

SHSE:688265's ROE % is ranked better than
80.3% of 1249 companies
in the Biotechnology industry
Industry Median: -38.61 vs SHSE:688265: 1.95

Shanghai Model Organisms Center  (SHSE:688265) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=2.736/1710.9705
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(2.736 / 399.668)*(399.668 / 1974.633)*(1974.633 / 1710.9705)
=Net Margin %*Asset Turnover*Equity Multiplier
=0.68 %*0.2024*1.1541
=ROA %*Equity Multiplier
=0.14 %*1.1541
=0.16 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=2.736/1710.9705
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (2.736 / 1.584) * (1.584 / 8.868) * (8.868 / 399.668) * (399.668 / 1974.633) * (1974.633 / 1710.9705)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1.7273 * 0.1786 * 2.22 % * 0.2024 * 1.1541
=0.16 %

Note: The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Shanghai Model Organisms Center ROE % Related Terms


Shanghai Model Organisms Center ROE % Historical Data

* Premium members only.

The historical data trend for Shanghai Model Organisms Center's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Model Organisms Center ROE % Chart

Shanghai Model Organisms Center Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.97 -0.30 -1.18 0.38 1.85

Shanghai Model Organisms Center Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.23 4.54 2.03 1.10 0.16

SHSE:688265 vs VRTX, REGN, RVMD: ROE % Comparison

For the Biotechnology subindustry, Shanghai Model Organisms Center's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Model Organisms Center ROE % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Model Organisms Center's ROE % distribution charts can be found below:

* The bar in red indicates where Shanghai Model Organisms Center's ROE % falls into.


SHSE:688265
78GF Score
Shanghai Model Organisms Center Inc SHSE:688265
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Model Organisms Center ROE % Calculation

Shanghai Model Organisms Center's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=31.437/( (1683.001+1709.188)/ 2 )
=31.437/1696.0945
=1.85 %

Shanghai Model Organisms Center's annualized ROE % for the quarter that ended in Mar. 2026 is calculated as

ROE %=Net Income (Q: Mar. 2026 )/( (Total Stockholders Equity (Q: Dec. 2025 )+Total Stockholders Equity (Q: Mar. 2026 ))/ count )
=2.736/( (1709.188+1712.753)/ 2 )
=2.736/1710.9705
=0.16 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2026) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 0.16% mean?
Shanghai Model Organisms Center (SHSE:688265) has a ROE % of 0.16% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Shanghai Model Organisms Center and its competitors. This is 96% below median its historical median of 3.91. According to the industry distribution chart, Shanghai Model Organisms Center ranks #246 out of 1249 companies in the Biotechnology industry, placing it in the top 19.7%.
Is Shanghai Model Organisms Center's ROE % too high?
Shanghai Model Organisms Center's current ROE % of 0.16% is 96% below median its 10-year median of 3.91. Based on the distribution chart, Shanghai Model Organisms Center ranks #246 out of 1249 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Shanghai Model Organisms Center has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Model Organisms Center's ROE % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shanghai Model Organisms Center ranks #246 out of 1249 companies for ROE %. This places Shanghai Model Organisms Center in the top 20% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Biotechnology company?
A good ROE % depends on the Biotechnology industry context. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Shanghai Model Organisms Center and its competitors. Shanghai Model Organisms Center's current ROE % is 0.16%, which is 96% below median its own 10-year median of 3.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Model Organisms Center stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Model Organisms Center (SHSE:688265) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥47.95, compared to a current price of ¥31.62 — trading 34.1% below its estimated fair value. The current ROE % is 0.16%, which is 96% below median its 10-year median of 3.91. Shanghai Model Organisms Center's overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Shanghai Model Organisms Center (SHSE:688265), the current ROE % is 0.16% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Model Organisms Center (SHSE:688265) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Model Organisms Center stock appears to be undervalued. The current stock price of ¥31.62 is trading 34.1% below its estimated GF Value™ of ¥47.95. GuruFocus considers Shanghai Model Organisms Center to be Significantly Undervalued.

Key valuation signals for SHSE:688265:

  • ROE %: 0.16% (96% below median its 10-year median of 3.91)
  • GF Value™: ¥47.95 vs. price of ¥31.62 (34.1% below fair value)
  • GF Score™: 78/100 with 5 warning signs

No single metric tells the full story. See the SHSE:688265 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Model Organisms Center Business Description

Address No.178 Banxia Road, Floor 2-4, Building 2, Pudong New Area, Shanghai, CHN, 201318
Shanghai Model Organisms Center Inc is engaged in model organisms and is dedicated to gene editing and life decoding. It provides customized solutions such as genetically engineered animal models, phenotype analysis and high-throughput screenings to advance life science research and drug discovery.
78GF Score

Get the complete analysis for SHSE:688265

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥31.62
Price
¥47.95
GF Value